TrialStem cell research & therapy2025

Phase II trial of intravenous human dental pulp stem cell therapy for Huntington's disease: a randomized, double-blind, placebo-controlled study.

Joyce Macedo Sanches Fernandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.